Mutation Changes in the preC/Core Promoter in HBeAg-Positive Patients With Chronic Hepatitis B During Interferon Therapy

To study the changes in 3 mutations related with hepatitis B e antigen (HBeAg) in patients with HBeAg-positive chronic hepatitis B (CHB) during interferon therapy. HBeAg seroconversion is a major therapeutic milestone for patients with HBeAg-positive CHB. The precore mutation G1896A and the basal co...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Yan, Wang, Xiangling, Lu, Xiaolan, Wu, Xiaokang, Xu, Nan, Han, Lei, Xu, Jiru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748907/
https://www.ncbi.nlm.nih.gov/pubmed/26844490
http://dx.doi.org/10.1097/MD.0000000000002657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748907/
https://www.ncbi.nlm.nih.gov/pubmed/26844490
http://dx.doi.org/10.1097/MD.0000000000002657

Ejemplares similares